参附注射液抑制HMGB1核转位保护内毒素休克大鼠肺损伤
|
摘要
目的:探讨参附注射液保护内毒素休克大鼠肺损伤的分子机制。方法:经腹腔注射脂多糖(LPS)建立内毒素休克SD大鼠模型,用5ml/kg、10ml/kg、15ml/kg剂量参附注射液干预,观察肺组织病理改变,检测肺组织中高迁移率族蛋白B1(HMGB1)的转录、表达、亚细胞定位及血浆中HMGB1分泌水平。结果:LPS可致SD大鼠肺泡隔水肿,充血,大量粒细胞浸润;肺组织中HMGB1的转录和表达均显著上调;胞浆中HMGB1表达显著增加,而核内HMGB1则显著下调;血浆中HMGB1水平明显上升。与模型组比较,参附注射液各剂量均可减轻内毒素休克大鼠肺组织水肿、充血和炎性细胞渗出,对肺损伤具有明显的保护作用,10ml/kg组病理评分最低;抑制内毒素休克大鼠肺组织中HMGB1的转录(呈剂量依赖性)、翻译和核转位(以10ml/kg组效果最优);抑制HMGB1分泌出胞,减少血浆中HMGB1含量(呈剂量依赖性)。结论:参附注射液抑制内毒素休克大鼠肺组织中HMGB1的核转位,可能是其扶阳固脱的重要分子机制。
Objective: To investigate the molecular mechanism of Shenfu Injection on protecting lung injury in endotoxin shock rats. Methods: Lipopolysaccharide( LPS) was intraperitoneally injected to SD rats to establish the endotoxin shock model. Animals were administered with Shenfu injection( 5 ml/kg、10 ml/kg、15 ml/kg doses). The pathological changes of lung tissues were observed. The transcription,expression,subcellular localization of high mobility group protein( HMGB1) in lung tissues and the secretion of HMGB1 in plasma were detected. Results: Thickened alveolar septa,pulmonary capillary hyperemia and notable inflammatory cell infiltration were readily identified after a stimulation by LPS. The transcription and expression of HMGB1 in lung tissues were significantly up regulated in LPS group. LPS markedly increased cytoplasmic HMGB1,and decreased nuclear HMGB1. The secretion of HMGB1 in plasma obviously increased in LPS group. Compared with LPS group,SFI reduced pathological changes in lung tissues( The pathological score was the lowest in 10 ml/kg group),downregulated the transcription( in dose-dependent manner),the expression and the translocation of HMGB1 in the cells of lung tissues( 10 ml/kg dose group had the best effect),as wells as the secretion of HMGB1 in plasma( in dose-dependent manner). Conclusion: Shenfu injection can significantly inhibit the nuclear translocation of HMGB1 in lung tissues and the secretion of HMGB1 in plasma of endotoxin shock rats,which may be an important molecular mechanism of its Fuyanggutuo effect.
Objective: To investigate the molecular mechanism of Shenfu Injection on protecting lung injury in endotoxin shock rats. Methods: Lipopolysaccharide( LPS) was intraperitoneally injected to SD rats to establish the endotoxin shock model. Animals were administered with Shenfu injection( 5 ml/kg、10 ml/kg、15 ml/kg doses). The pathological changes of lung tissues were observed. The transcription,expression,subcellular localization of high mobility group protein( HMGB1) in lung tissues and the secretion of HMGB1 in plasma were detected. Results: Thickened alveolar septa,pulmonary capillary hyperemia and notable inflammatory cell infiltration were readily identified after a stimulation by LPS. The transcription and expression of HMGB1 in lung tissues were significantly up regulated in LPS group. LPS markedly increased cytoplasmic HMGB1,and decreased nuclear HMGB1. The secretion of HMGB1 in plasma obviously increased in LPS group. Compared with LPS group,SFI reduced pathological changes in lung tissues( The pathological score was the lowest in 10 ml/kg group),downregulated the transcription( in dose-dependent manner),the expression and the translocation of HMGB1 in the cells of lung tissues( 10 ml/kg dose group had the best effect),as wells as the secretion of HMGB1 in plasma( in dose-dependent manner). Conclusion: Shenfu injection can significantly inhibit the nuclear translocation of HMGB1 in lung tissues and the secretion of HMGB1 in plasma of endotoxin shock rats,which may be an important molecular mechanism of its Fuyanggutuo effect.
引文
[1]Lozano C, Torres C. Update on antibiotic resistance in Gram-positive bacteria. Enfermedades Infecciosas Y Microbiologia Clinica, 2017, 35 Suppl 1∶2.
[2]Blank R, Napolitano L M. Epidemiology of ARDS and ALI. Critical Care Clinics, 2011, 27(3)∶439～458.
[3]Kang R, Chen R, Zhang Q, et al. HMGB1 in health and disease. Molecular Aspects of Medicine, 2014, 40∶1-116. DOI:10.1016/j.mam.2014.05.001.
[4]Bonaldi, T, Talamo F, Scaffidi P, et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO (European Molecular Biology Organization) Journal, 2003, 22(20)∶5551～5560.
[5]Hudson B I, Lippman M E. Targeting RAGE Signaling in Inflammatory Disease. Annual Review of Medicine, 2017, 69(1):349～364.
[6]Weber D J, Allette Y M, Wilkes D S, et al. The HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury-Induced Pulmonary Dysfunction. Antioxidants & Redox Signaling, 2015, 23(17)∶1316～1328.
[7]熊利红,秦丹梅. 参附注射液治疗休克临床观察中国中医急症,2013, 22(1)∶156.
[8]何木龙,陈少军. 参附注射液治疗休克(厥脱证)38例的临床观察. 实用中西医结合临床,2016, 16(1)∶20～22.
[9]熊旭东,徐康雅,曹伦. 参附注射液治疗厥脱四期临床验证. 中国中医急症, 2005, 14(8)∶745～746.
[10]Kotanidou A, Loutrari H, Papadomichelakis E, et al. Inhaled activated protein C attenuates lung injury induced by aerosolized endotoxin in mice. Vascular Pharmacology, 2006, 45(2):134～140.
[11]Vincent J L, Opal S M, Marshall J C, et al. Sepsis definitions: time for change. The Lancet, Lancet, 2013, 381(9868)∶774～775.
[12]Yu-Hang A I, Peng L. Protective effect of Shenfu injection on endotoxin induced acute lung injury. Chinese Journal of Critical Care Medicine, 2006, 26(4)∶285～286.
[13]廖文生,李卫青,陈世伟,等. 参附注射液对慢性阻塞性肺疾病急性加重期患者炎症细胞因子和肺功能的影响. 中国中西医结合急救杂志,2008, 15(3)∶149～151.
[14]王进,乔礼芬,李永胜,等. 参附注射液对脂多糖诱导的大鼠肺泡巨噬细胞核因子-κB的激活和细胞因子产生的影响. 华中科技大学学报(医学版),2009, 38(1)∶15～18.
[15]Wang H. HMG-1 as a Late Mediator of Endotoxin Lethality in Mice. Science, 1999, 285(5425)∶248～251.
[16]Luan Z G, Zhang H, Yang P T, et al. HMGB1 activates nuclear factor-kappaB signaling by RAGE and increases the production of TNF-alpha in human umbilical vein endothelial cells. Immunobiology, 2010, 215(12)∶956～962.
[17]Wang G, Han D, Zhang Y, et al. A novel hypothesis: up-regulation of HO-1 by activation of PPARgamma inhibits HMGB1-RAGE signaling pathway and ameliorates the development of ALI/ARDS. J Thorac Dis, 2013, 5(5)∶706～710.
[18]Weber D J, Allette Y M, Wilkes D S, et al. The HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury-Induced Pulmonary Dysfunction. Antioxidants & Redox Signaling, 2015, 23(17)∶1316～1328.
[19]Yanai H , Matsuda A , An J , et al. Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection. Proceedings of the National Academy of Sciences, 2013, 110(51):20699～20704.
[20]Kang R, Zhang Q, Hou W, et al. Intracellular Hmgb1 inhibits inflammatory nucleosome release and limits acute pancreatitis in mice. Gastroenterology, 2014, 146(4)∶1097～1107.
[21]Huang H, Nace G W, Mcdonald K A, et al. Hepatocyte-specific high-mobility group box 1 deletion worsens the injury in liver ischemia/reperfusion∶a role for intracellular high-mobility group box 1 in cellular protection. Hepatology, 2014, 59(5)∶1984～1997.
[2]Blank R, Napolitano L M. Epidemiology of ARDS and ALI. Critical Care Clinics, 2011, 27(3)∶439～458.
[3]Kang R, Chen R, Zhang Q, et al. HMGB1 in health and disease. Molecular Aspects of Medicine, 2014, 40∶1-116. DOI:10.1016/j.mam.2014.05.001.
[4]Bonaldi, T, Talamo F, Scaffidi P, et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO (European Molecular Biology Organization) Journal, 2003, 22(20)∶5551～5560.
[5]Hudson B I, Lippman M E. Targeting RAGE Signaling in Inflammatory Disease. Annual Review of Medicine, 2017, 69(1):349～364.
[6]Weber D J, Allette Y M, Wilkes D S, et al. The HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury-Induced Pulmonary Dysfunction. Antioxidants & Redox Signaling, 2015, 23(17)∶1316～1328.
[7]熊利红,秦丹梅. 参附注射液治疗休克临床观察中国中医急症,2013, 22(1)∶156.
[8]何木龙,陈少军. 参附注射液治疗休克(厥脱证)38例的临床观察. 实用中西医结合临床,2016, 16(1)∶20～22.
[9]熊旭东,徐康雅,曹伦. 参附注射液治疗厥脱四期临床验证. 中国中医急症, 2005, 14(8)∶745～746.
[10]Kotanidou A, Loutrari H, Papadomichelakis E, et al. Inhaled activated protein C attenuates lung injury induced by aerosolized endotoxin in mice. Vascular Pharmacology, 2006, 45(2):134～140.
[11]Vincent J L, Opal S M, Marshall J C, et al. Sepsis definitions: time for change. The Lancet, Lancet, 2013, 381(9868)∶774～775.
[12]Yu-Hang A I, Peng L. Protective effect of Shenfu injection on endotoxin induced acute lung injury. Chinese Journal of Critical Care Medicine, 2006, 26(4)∶285～286.
[13]廖文生,李卫青,陈世伟,等. 参附注射液对慢性阻塞性肺疾病急性加重期患者炎症细胞因子和肺功能的影响. 中国中西医结合急救杂志,2008, 15(3)∶149～151.
[14]王进,乔礼芬,李永胜,等. 参附注射液对脂多糖诱导的大鼠肺泡巨噬细胞核因子-κB的激活和细胞因子产生的影响. 华中科技大学学报(医学版),2009, 38(1)∶15～18.
[15]Wang H. HMG-1 as a Late Mediator of Endotoxin Lethality in Mice. Science, 1999, 285(5425)∶248～251.
[16]Luan Z G, Zhang H, Yang P T, et al. HMGB1 activates nuclear factor-kappaB signaling by RAGE and increases the production of TNF-alpha in human umbilical vein endothelial cells. Immunobiology, 2010, 215(12)∶956～962.
[17]Wang G, Han D, Zhang Y, et al. A novel hypothesis: up-regulation of HO-1 by activation of PPARgamma inhibits HMGB1-RAGE signaling pathway and ameliorates the development of ALI/ARDS. J Thorac Dis, 2013, 5(5)∶706～710.
[18]Weber D J, Allette Y M, Wilkes D S, et al. The HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury-Induced Pulmonary Dysfunction. Antioxidants & Redox Signaling, 2015, 23(17)∶1316～1328.
[19]Yanai H , Matsuda A , An J , et al. Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection. Proceedings of the National Academy of Sciences, 2013, 110(51):20699～20704.
[20]Kang R, Zhang Q, Hou W, et al. Intracellular Hmgb1 inhibits inflammatory nucleosome release and limits acute pancreatitis in mice. Gastroenterology, 2014, 146(4)∶1097～1107.
[21]Huang H, Nace G W, Mcdonald K A, et al. Hepatocyte-specific high-mobility group box 1 deletion worsens the injury in liver ischemia/reperfusion∶a role for intracellular high-mobility group box 1 in cellular protection. Hepatology, 2014, 59(5)∶1984～1997.